Armistice Capital »

Motus Gi Hldgs shares owned by Armistice Capital

Quarter-by-quarter ownership of Motus Gi Hldgs shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Motus Gi Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Motus Gi Hldgs held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Motus Gi Hldgs by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $255k 567k 0.45
2023-06-30 $183k 273k 0.67

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Supernus Pharmaceuticals (SUPN)
Argenx Se Sponsored Adr (ARGX)
Deciphera Pharmaceuticals (DCPH)
Agios Pharmaceuticals (AGIO)
Immunovant (IMVT)
Sanofi Sponsored Adr (SNY)
Aurinia Pharmaceuticals (AUPH)
Dentsply Sirona (XRAY)
Travere Therapeutics (TVTX)

View all positions for Armistice Capital